Guy P. Nohra
Known title: DirectorCIK: 0001198330
Associated companies
Transaction History
| TELA | ▲ Buy | Grant | 11,925 | $0 | 6/9/2026 | View on chart |
| TELA | ▲ Buy | Grant | 11,675 | $0 | 6/9/2026 | View on chart |
| BVS | ▲ Buy | Option Exercise | 32,282 | $0 | 6/2/2026 | View on chart |
| BVS | ▼ Sell | Open Market | 10,000 | $76K | 12/4/2025 | View on chart |
| BVS | ▲ Buy | Option Exercise | 26,493 | $0 | 6/2/2025 | View on chart |
| BVS | ▲ Buy | Option Exercise | 30,400 | $0 | 6/7/2024 | View on chart |
| BVS | ▼ Sell | Other | 41,369 | $0 | 8/16/2023 | View on chart |
| BVS | ▲ Buy | Option Exercise | 16,648 | $0 | 6/6/2023 | View on chart |
| BVS | ▲ Buy | Option Exercise | 2,700 | — | 4/1/2022 | View on chart |
| BVS | ▲ Buy | Option Exercise | 9,000 | — | 2/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Craig-Hallum initiates coverage on TELA Bio with $2 target
Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.
Craig-Hallum initiates coverage on TELA Bio with $2 target. Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.